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Many drugs have been tested for their effect in vitro on the growth of the tubercle bacillus; some of these have been tested in experimental tuberculosis in animals and some have been given clinical trials (Feldman, 1946 The dosage of PAS usually recommended is 20 g. per day for adults, given in divided doses four times a day, but it is wise to start with a smaller dosage, such as I2 g. per day, which should be increased gradually. Side effects of the drug are anorexia, nausea and vomiting, which tend to occur at the start of treatment. Different forms of the drug have been produced in an attempt to counteract these side effects; our experience has been that the granule form is that best tolerated and that if the dose is increased slowly, digestive disturoances usually subside as treatment is continued.
The place of other antibiotics and antibacterial substance$ introduced for the treatment of tuberculosis has recently been summarized by Scadding (i95i).
Treatment of Tuberculous Lymphadenitis
General measures such as bed rest Girdlestone (1940) and Mercer (1950) . Importance is stiU attached to general measures such as bed rest, sunlight and fresh air. Immobilization of the affected part and reduction of the deformity are the main aims of treatment; in adults excision of the infected joint or arthrodesis are often necessary. Treatment with streptomycin and PAS has not produced startling improvement in the actual bony disease, but it has been impressive in reducing cachexia and allowing tuberculous sinuses to heal.
In joint tuberculosis, Streeten (I.949) claimed rapid improvement and relief of pain with cure and useful mobility in the synovial type of disease, by preliminary alkalinization of the joint space with sodium hydroxide and borax buffer solution; streptomycin 0.2 to 0.5 g. was then injected daily into the joint cavity. Unfortunately the follow-up period in his cases was too short to give a final assessment of the method.
At present most workers use the classical methods of treatment outlined above with, in addition, intramuscular streptomycin i g. per day and oral PAS 20 g. per day. Should tuberculous sinuses arise, local streptomycin is given as well. Cold abscesses should be treated conservatively if possible; aspiration and replacement with streptomycin solution may be used but incision should be reserved for cases where the skin is discoloured and about to break, or the abscess is spreading, or where there is pressure on vital parts or secondary infection. In all cases of secondary infection the infecting organism should be isolated and the appropriate antibiotic given after in vitro sensitivity tests.
As in cases; of tuberculous adenitis there is no dramatic cure of the underlying disease with streptomycin therapy, but tuberculous sinuses can be expected to close and cachexia is relieved.
Tuberculous Sinuses
Tuberculous sinuses may be treated with streptomycin given locally (Ahem, 1950) , or the vdrvgpay. be given systemically with oral PAS (Davis, I949). The adherents of local treatment alone argue that their results as regards closure of the sinuses are as good as when systemic treatment also is given, but that their method has the advantage of saving the patient much discomfort from repeated intramuscular injections. They also state that though the drug is only given locally, therapeutic blood levels are obtained and the concentration of the drug at the site of the infection is greater than that obtained by intramuscular treatment alone. There is, however, always a greater chance of producing drug sensitivity when any antibiotic drug is administered in large doses locally, and there is also the danger that the drug may not penetrate through dense granulation tissue and necrotic d6bris in sufficiently high concentrations to exert a bacteriostatic effect on deepseated viable tubercle bacilli. If a deep focus of infection is suspected, it is better to treat this either by systemic streptomycin and PAS, or by surgery, the sinus itself being treated by local applications of streptomycin.
Results of streptomycin treatment in closure of sinuses are excellent, but there is always a danger of breakdown unless the underlying infection can -be removed or controlled.
Treatment of Tuberculous Peritonitis
Only three cases of tuberculous peritonitis treated with streptomycin have been reported in this country, and in all the results were most successful (Grant et al., 1951; Salmon, 1951 content of the fluid is estimated. Levels of more than 2 microg. per ml. on intramuscular treatment alone indicate breakdown of the blood-brain barrier, strongly suggesting activity of the meningitic process. The protein content of the spinal fluid is of little value in estimating activity of the disease as it may take months to return to normal after the patient has otherwise recovered completely. If improvement is maintained when intrathecal therapy has been stopped for a month, intramuscular treatment may be discontinued. After a further period of observation in hospital, adults should be sent to convalescence, and children, if practicable, to a convalescent school.
After streptomycin treatment is stopped, monthly clinical and lumbar puncture exantinations should be carried out to check progress, and if this is maintained the intervals between examinations can be progressively lengthened.
Damage to the vestibular apparatus occurs in nearly all cases, and is no indication for withholding treatment. Survivors under the age of 50 years are left with little residual disability owing to the development of other compensating mechanisms. One of our survivors, a child with absent labyrinthine response to ice water, successfully learnt to skate.
Deafness is not considered to be an indication for stopping treatment. Once it has occurred, it is doubtful whether recovery will take place even if streptomycin treatment is stopped immediately.
Additional drug treatment
Para-amino salicylic acid should be given orally to all cases concurrently with streptomycin therapy.
Sulphetrone has been popular on the Continent as an adjuvant to streptomycin treatment. In this country results after giving the drug by mouth have been unconvincing, and it is considered that severe toxic effects occur too frequently to justify its routine use orally. It has been used intrathecally, but again with inconclusive results tCathie and MacFarlane, 1950) .
Streptokinase is an enzyme obtained from
Streptococcus pyogenes which will lyse fibrinous exudate in vitro. It has been used intrathecally in an attempt to prevent adhesions and block (Cathie, 1949) . Lorber, assessing the value of the drug with a control series of cases, has recently shown that its efficacy is very doubtful. As it may itself produce meningeal irritation the use of the enzyme is probably no longer justifiable. Intrathecal tuberculin. Smith and Vollum (1950) have suggested that one of the factors in tuberculous meningitis restricting the survival rate, and perhaps explaining the occurrence and disappear- ' The GeBiesis of Mammary Cancer in Mice.' He described experiments which had been performed with strains of mice which had been maintained for more than zo generatio'ns by brother-to-sister mating. Some of these strains were infected with the ' milk agent' which is responsible for some mammary carcinomata in those truce hereditarily susceptible to its influence. Suspensions' of the agent, when diluted within limits, produced a highet incidence of cancer than when undiluted. With repeated doses a smaller incidence of cancer was obtained than with single doses in other mice and their progeny. These last two facts suggest that an active immunity could be developed against the milk agent. Tumour material which had been frozen and dried produced tumours at the site of inoculation in those mice which would support growth of transplants of fresh tumour materialmore tumours were produced by intraperitoneal than by subcutaneous' injections. Evidence showed that male mice had infected females with the milk agent.
Dr. Bittner showed pictures of sections of whole mammary glands in which there were hyperplastic nodules said by some to be precancerous and to be associated with those breasts susceptible to the milk agent. He stated that some were of the opinion that the degree to which breasts produced hyperplastic nodules i-n response to artificially administered oestrogens was directly proportional to their susceptibility to the milk agent. This observation, together with further evidence adduced from experiments on various strains of mice in which ovariectomy and transplantation of ovaries and aarenals were carried out, led to the hypothesis that the milk agent was responsible for altering the hormone balance of mice infected with it. Finally, in support of this hypothesis there was the striking fact that those mice infected by the milk agent excreted a smaller amount of 17-ketosteroids than those free of agent. Dr. Bittner said it was possible that alteration of the hormone balance was directly responsible for the production of mammary cancer in mice, and that the role of the milk agent might merely be that of upsetting the hormones.
In mice there occur mammary adenocarcinomata, both spontaneous and chemically induced, which are not associated with the milk agent; thus, arguing by analogy, it is possible that there are several kinds of human breast cancer one of which may be transmitted by a milk agent. If this is so, it must be borne in mind that-human females could be infected from the male or by such things as blood transfusion. However, Dr. Bittner calculated that it would be at least 8o years before it could be determined whether a milk agent played any part in human breast cancer.
